Related Experiment Video
Updated: Jul 6, 2026

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Scattering differentiates Alzheimer disease in vitro
Eugene B Hanlon1, Lev T Perelman, Eduard I Vitkin
1Department of Veterans Affairs, Office of Research and Development, and Geriatric Research, Education and Clinical Center, 200 Springs Road, Bedford, Massachusetts 01730, USA. Eugene.Hanlon@med.va.gov
Near-infrared optical spectroscopy can differentiate Alzheimer disease brain tissue from healthy tissue. This technique shows promise for non-invasive diagnosis and monitoring of Alzheimer disease in living patients.
Area of Science:
- Neuroscience
- Biomedical Optics
- Medical Diagnostics
Background:
- Understanding Alzheimer disease (AD) molecular pathology is advancing.
- Definitive in vivo diagnosis and monitoring of AD remain challenging.
- Near-infrared (NIR) optical spectroscopy presents a potential diagnostic solution.
Purpose of the Study:
- To investigate the utility of NIR optical spectroscopy for differentiating Alzheimer disease brain tissue.
- To explore the potential for in vivo diagnosis and monitoring of AD.
Main Methods:
- Acquired transmission and reflectance spectra from thin brain tissue slabs (470-1000 nm).
- Calculated wavelength-dependent absorption and reduced scattering coefficients.
- Analyzed diffuse reflectance spectra of gross brain tissue in vitro.
Main Results:
- Reduced scattering coefficients in the NIR range effectively distinguished Alzheimer disease specimens from controls.
- In vitro diffuse reflectance spectra corroborated these findings.
- NIR spectroscopy demonstrated potential for differentiating AD-affected brain tissue.
Conclusions:
- NIR optical spectroscopy can identify spectral differences in brain tissue associated with Alzheimer disease.
- This technique offers a promising non-invasive method for in vivo diagnosis and monitoring of Alzheimer disease.
- Further research may validate NIR spectroscopy for clinical application in AD management.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer's Disease: Treatment
